Second generation registry framework

First- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry)

BACKGROUND There are sparse data on the performance of different types of drug-eluting stents (DES) in acute and real-life setting. OBJECTIVE The aim of the study was to compare the safety and efficacy of first- versus second-generation DES in patients with acute coronary syndromes (ACS). METHODS This all-comer registry enrolled consecutive patients diagnosed with ACS and treated with percu...

First-Generation Versus Second-Generation Drug-Eluting Stents in Coronary Chronic Total Occlusions: Two-Year Results of a Multicenter Registry

BACKGROUND Limited data are available regarding the long-term clinical outcomes of second-generation drug-eluting stents (DES) versus first-generation DES in patients with coronary chronic total occlusion (CTO) who undergo percutaneous coronary intervention (PCI). The aim of this study was to compare the clinical outcomes of second-generation DES with those of first-generation DES for the treat...

Resilience-Based Framework for Distributed Generation Planning in Distribution Networks

Events with low probability and high impact, which annually cause high damages, seriously threaten the health of the distribution networks. Hence, more attention to the issue of enhancing network resilience and continuity of power supply, feels more than ever, all over the world. In modern distribution networks, because of the increasing presence of distributed generation resources, an alternat...

Iranian Joint Registry(Iranian National Hip and Knee Arthroplasty Registry)

   Periodic evaluation and monitoring the health and economic outcome of joint replacement surgery is a common and popular process under the territory of joint registries in many countries. In this article we introduce the methodology used for the foundation of the National Iranian Joint Registry (IJR) with a joint collaboration of the Social Security Organization (SSO) and academic research de...

Second-generation antidepressants.